000 04786nam a22005655i 4500
001 978-3-031-54513-9
003 DE-He213
005 20251030112033.0
007 cr nn 008mamaa
008 240509s2024 sz | s |||| 0|eng d
020 _a9783031545139
_9978-3-031-54513-9
024 7 _a10.1007/978-3-031-54513-9
_2doi
050 4 _aRL1-803
072 7 _aMJK
_2bicssc
072 7 _aMED017000
_2bisacsh
072 7 _aMJK
_2thema
245 1 0 _aManagement of Atopic Dermatitis
_h[electronic resource] :
_bMethods and Challenges /
_cedited by Steven R. Feldman, Lindsay C. Strowd, Katie K. Lovell.
250 _a2nd ed. 2024.
264 1 _aCham :
_bSpringer International Publishing :
_bImprint: Springer,
_c2024.
300 _aX, 248 p. 9 illus., 7 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aAdvances in Experimental Medicine and Biology,
_x2214-8019 ;
_v1447
505 0 _aIntroduction -- Atopic Dermatitis: Disease Background and Risk Factors -- Atopic Dermatitis: Pathophysiology -- Clinical Presentation of Atopic Dermatitis -- Special Considerations for Atopic Dermatitis in Skin of Color Patients -- Atopic Dermatitis Disease Complications -- The Psychosocial Impact of Atopic Dermatitis -- Stressors in Atopic Dermatitis -- The Economics Burden of Atopic Dermatitis -- Defining and Measuring the Scope of Atopic Dermatitis -- Topical Prescription Management (including new topical JAK) -- Oral Prescription Management (including new oral JAKs).-Introduction -- Atopic Dermatitis: Disease Background and Risk Factors -- Atopic Dermatitis: Pathophysiology -- Clinical Presentation of Atopic Dermatitis -- Special Considerations for Atopic Dermatitis in Skin of Color Patients -- Atopic Dermatitis Disease Complications -- The Psychosocial Impact of Atopic Dermatitis -- Stressors in Atopic Dermatitis -- The Economics Burden of Atopic Dermatitis -- Defining and Measuring the Scope of Atopic Dermatitis -- Topical Prescription Management (including new topical JAK) -- Oral Prescription Management (including new oral JAKs) -- Systemic Biologic Management (dupilumab and tralokinumab) -- Non-Prescription Treatment Options -- Adherence in Atopic Dermatitis -- Atopic Dermatitis: Managing the Itch -- Atopic Dermatitis Disease Education -- Guidelines from American Academy of Dermatology -- The Future of Atopic Dermatitis Treatment (to be updated—some drugs discussed in this chapter are now FDA approved).
520 _aThis new edition builds upon the foundational knowledge covered in the first edition, covering the epidemiology, pathogenesis, and clinical presentation of atopic dermatitis in both pediatric and adult patients. It provides an overview of the mechanism and presentation of atopic dermatitis and focuses on the management methods experienced dermatologists have used to successfully manage atopic dermatitis. The book includes new chapters describing the special considerations for atopic dermatitis in skin of color patients, dedicated chapters on topical and oral prescription management reflected the latest FDA-approved treatments, and also a chapter covering the updated guidelines from the American Academy of Dermatology. A final chapter includes updates on the future of atopic dermatitis treatment. This book provides physicians with insights into the management of atopic dermatitis, such as alternative treatments for pruritus, psychosocial impact on patients and families, assessing patient compliance, and patient resources.
650 0 _aDermatology.
_972926
650 0 _aEpidemiology.
_965983
650 0 _aPathology.
_974914
650 1 4 _aDermatology.
_972926
650 2 4 _aEpidemiology.
_965983
650 2 4 _aPathology.
_974914
700 1 _aFeldman, Steven R.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_964928
700 1 _aStrowd, Lindsay C.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_976561
700 1 _aLovell, Katie K.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_976562
710 2 _aSpringerLink (Online service)
773 0 _tSpringer Nature eBook
776 0 8 _iPrinted edition:
_z9783031545122
776 0 8 _iPrinted edition:
_z9783031545146
776 0 8 _iPrinted edition:
_z9783031545153
830 0 _aAdvances in Experimental Medicine and Biology,
_x2214-8019 ;
_v1447
_967831
856 4 0 _uhttps://doi.org/10.1007/978-3-031-54513-9
912 _aZDB-2-SBL
912 _aZDB-2-SXB
999 _c59732
_d59732